Cargando…
Cilostazol suppresses angiotensin II-induced apoptosis in endothelial cells
Patients with essential hypertension undergo endothelial dysfunction, particularly in the conduit arteries. Cilostazol, a type III phosphodiesterase inhibitor, serves a role in the inhibition of platelet aggregation and it is widely used in the treatment of peripheral vascular diseases. Previous stu...
Autores principales: | SHI, MIAO-QIAN, SU, FEI-FEI, XU, XUAN, LIU, XIONG-TAO, WANG, HONG-TAO, ZHANG, WEI, LI, XUE, LIAN, CHENG, ZHENG, QIANG-SUN, FENG, ZHI-CHUN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768974/ https://www.ncbi.nlm.nih.gov/pubmed/26862035 http://dx.doi.org/10.3892/mmr.2016.4881 |
Ejemplares similares
-
Alpha-Asarone Protects Endothelial Cells from Injury by Angiotensin II
por: Shi, Hai-Xia, et al.
Publicado: (2014) -
Endothelial Dysfunction in the Smokers Can Be Improved with Oral Cilostazol Treatment
por: Kim, Kyu Seop, et al.
Publicado: (2011) -
Endothelial-specific deletion of Ets-1 attenuates Angiotensin II-induced cardiac fibrosis via suppression of endothelial-to-mesenchymal transition
por: Xu, Lian, et al.
Publicado: (2019) -
Cilostazol inhibits plasmacytoid dendritic cell activation and antigen presentation
por: Sun, Fei, et al.
Publicado: (2015) -
p120 catenin attenuates the angiotensin II-induced apoptosis of human umbilical vein endothelial cells by suppressing the mitochondrial pathway
por: ZHANG, YAN, et al.
Publicado: (2016)